Search

Paul R Michl

Examiner (ID: 9867)

Most Active Art Unit
1505
Art Unit(s)
1511, 3502, 1503, 2899, 1714, 1201, 1505, 1506, 3305, 1509
Total Applications
2093
Issued Applications
1688
Pending Applications
51
Abandoned Applications
353

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 558320 [patent_doc_number] => 07157425 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-01-02 [patent_title] => 'Apolipoprotein A-I agonists and their use to treat dyslipidemic disorders' [patent_app_type] => utility [patent_app_number] => 10/099574 [patent_app_country] => US [patent_app_date] => 2002-03-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 23 [patent_no_of_words] => 37034 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 284 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/157/07157425.pdf [firstpage_image] =>[orig_patent_app_number] => 10099574 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/099574
Apolipoprotein A-I agonists and their use to treat dyslipidemic disorders Mar 14, 2002 Issued
Array ( [id] => 6721546 [patent_doc_number] => 20030055236 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-03-20 [patent_title] => 'Secreted protein HKABT24' [patent_app_type] => new [patent_app_number] => 10/097065 [patent_app_country] => US [patent_app_date] => 2002-03-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 112873 [patent_no_of_claims] => 76 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0055/20030055236.pdf [firstpage_image] =>[orig_patent_app_number] => 10097065 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/097065
Secreted protein HKABT24 Mar 13, 2002 Abandoned
Array ( [id] => 6307847 [patent_doc_number] => 20020094956 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-07-18 [patent_title] => 'Use of alpha1beta1 integrin receptor inhibitors and TGF-beta1 inhibitors in the treatment of kidney disease' [patent_app_type] => new [patent_app_number] => 10/099573 [patent_app_country] => US [patent_app_date] => 2002-03-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 24 [patent_no_of_words] => 21811 [patent_no_of_claims] => 42 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0094/20020094956.pdf [firstpage_image] =>[orig_patent_app_number] => 10099573 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/099573
Use of alpha1beta1 integrin receptor inhibitors and TGF-beta1 inhibitors in the treatment of kidney disease Mar 11, 2002 Abandoned
Array ( [id] => 6553326 [patent_doc_number] => 20020138203 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-09-26 [patent_title] => 'Method and system for designing proteins and protein backbone configurations' [patent_app_type] => new [patent_app_number] => 10/093109 [patent_app_country] => US [patent_app_date] => 2002-03-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 4446 [patent_no_of_claims] => 57 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 88 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0138/20020138203.pdf [firstpage_image] =>[orig_patent_app_number] => 10093109 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/093109
Method and system for designing proteins and protein backbone configurations Mar 6, 2002 Abandoned
Array ( [id] => 5860597 [patent_doc_number] => 20020123846 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-09-05 [patent_title] => 'Method and system for designing proteins and protein backbone configurations' [patent_app_type] => new [patent_app_number] => 10/093108 [patent_app_country] => US [patent_app_date] => 2002-03-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 4453 [patent_no_of_claims] => 57 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 88 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0123/20020123846.pdf [firstpage_image] =>[orig_patent_app_number] => 10093108 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/093108
Method and system for designing proteins and protein backbone configurations Mar 6, 2002 Abandoned
Array ( [id] => 6687626 [patent_doc_number] => 20030031350 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-02-13 [patent_title] => 'Methods for large scale protein matching' [patent_app_type] => new [patent_app_number] => 10/087541 [patent_app_country] => US [patent_app_date] => 2002-03-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 5994 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 86 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0031/20030031350.pdf [firstpage_image] =>[orig_patent_app_number] => 10087541 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/087541
Methods for large scale protein matching Feb 28, 2002 Abandoned
10/084615 Platelet production promoting agent Feb 27, 2002 Abandoned
Array ( [id] => 7617002 [patent_doc_number] => 06946439 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-09-20 [patent_title] => 'Compositions and methods for inhibiting cellular proliferation comprising TFPI fragments' [patent_app_type] => utility [patent_app_number] => 10/086176 [patent_app_country] => US [patent_app_date] => 2002-02-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 10841 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 58 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/946/06946439.pdf [firstpage_image] =>[orig_patent_app_number] => 10086176 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/086176
Compositions and methods for inhibiting cellular proliferation comprising TFPI fragments Feb 27, 2002 Issued
Array ( [id] => 6646757 [patent_doc_number] => 20030104408 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-06-05 [patent_title] => 'Method and device for assembling nucleic acid base sequences' [patent_app_type] => new [patent_app_number] => 10/083338 [patent_app_country] => US [patent_app_date] => 2002-02-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 11387 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 114 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0104/20030104408.pdf [firstpage_image] =>[orig_patent_app_number] => 10083338 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/083338
Method and device for assembling nucleic acid base sequences Feb 26, 2002 Issued
Array ( [id] => 5922900 [patent_doc_number] => 20020115594 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-08-22 [patent_title] => 'Peptide antagonists at glutamate and NMDA receptors' [patent_app_type] => new [patent_app_number] => 10/087011 [patent_app_country] => US [patent_app_date] => 2002-02-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 6964 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 22 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0115/20020115594.pdf [firstpage_image] =>[orig_patent_app_number] => 10087011 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/087011
Peptide antagonists at glutamate and NMDA receptors Feb 25, 2002 Abandoned
Array ( [id] => 6787615 [patent_doc_number] => 20030138854 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-07-24 [patent_title] => 'Method for determining BAGE expression' [patent_app_type] => new [patent_app_number] => 10/081108 [patent_app_country] => US [patent_app_date] => 2002-02-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 7456 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0138/20030138854.pdf [firstpage_image] =>[orig_patent_app_number] => 10081108 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/081108
Method for determining BAGE expression Feb 19, 2002 Abandoned
Array ( [id] => 796555 [patent_doc_number] => 07430476 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-09-30 [patent_title] => 'Method for identification of t-cell epitopes and use for preparing molecules with reduced immunogenicity' [patent_app_type] => utility [patent_app_number] => 10/468496 [patent_app_country] => US [patent_app_date] => 2002-02-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 35533 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 219 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/430/07430476.pdf [firstpage_image] =>[orig_patent_app_number] => 10468496 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/468496
Method for identification of t-cell epitopes and use for preparing molecules with reduced immunogenicity Feb 17, 2002 Issued
Array ( [id] => 6419429 [patent_doc_number] => 20020183937 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-12-05 [patent_title] => 'Method for the generation of proteins with new enzymatic function' [patent_app_type] => new [patent_app_number] => 10/074679 [patent_app_country] => US [patent_app_date] => 2002-02-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 24834 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 74 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0183/20020183937.pdf [firstpage_image] =>[orig_patent_app_number] => 10074679 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/074679
Method for the generation of proteins with new enzymatic function Feb 10, 2002 Abandoned
Array ( [id] => 6844586 [patent_doc_number] => 20030149933 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-08-07 [patent_title] => 'Graphical design of chemical discovery processes' [patent_app_type] => new [patent_app_number] => 10/061960 [patent_app_country] => US [patent_app_date] => 2002-02-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 8311 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 211 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0149/20030149933.pdf [firstpage_image] =>[orig_patent_app_number] => 10061960 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/061960
Graphical design of chemical discovery processes Jan 31, 2002 Abandoned
Array ( [id] => 6721530 [patent_doc_number] => 20030055220 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-03-20 [patent_title] => 'Protein-protein interactions between Shigella flexneri polypeptides and mammalian polypeptides' [patent_app_type] => new [patent_app_number] => 10/043487 [patent_app_country] => US [patent_app_date] => 2002-01-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 26996 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0055/20030055220.pdf [firstpage_image] =>[orig_patent_app_number] => 10043487 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/043487
Protein-protein interactions between Shigella flexneri polypeptides and mammalian polypeptides Jan 10, 2002 Abandoned
Array ( [id] => 6048889 [patent_doc_number] => 20020169264 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-11-14 [patent_title] => 'Polymers incorporating peptides' [patent_app_type] => new [patent_app_number] => 10/044034 [patent_app_country] => US [patent_app_date] => 2002-01-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 16339 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 57 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0169/20020169264.pdf [firstpage_image] =>[orig_patent_app_number] => 10044034 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/044034
Polymers incorporating peptides Jan 10, 2002 Abandoned
Array ( [id] => 6710970 [patent_doc_number] => 20030170719 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-09-11 [patent_title] => 'NF-kappa B activating gene' [patent_app_type] => new [patent_app_number] => 10/042211 [patent_app_country] => US [patent_app_date] => 2002-01-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 30 [patent_figures_cnt] => 30 [patent_no_of_words] => 20523 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0170/20030170719.pdf [firstpage_image] =>[orig_patent_app_number] => 10042211 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/042211
NF-kappa B activating gene Jan 6, 2002 Abandoned
Array ( [id] => 6745102 [patent_doc_number] => 20030022285 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-01-30 [patent_title] => 'Protein design automation for designing protein libraries with altered immunogenicity' [patent_app_type] => new [patent_app_number] => 10/039170 [patent_app_country] => US [patent_app_date] => 2002-01-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 32124 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 58 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0022/20030022285.pdf [firstpage_image] =>[orig_patent_app_number] => 10039170 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/039170
Protein design automation for designing protein libraries with altered immunogenicity Jan 3, 2002 Abandoned
Array ( [id] => 6715872 [patent_doc_number] => 20030027220 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-02-06 [patent_title] => 'Chemical modification' [patent_app_type] => new [patent_app_number] => 10/037212 [patent_app_country] => US [patent_app_date] => 2002-01-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 28325 [patent_no_of_claims] => 88 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0027/20030027220.pdf [firstpage_image] =>[orig_patent_app_number] => 10037212 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/037212
Chemical modification Jan 3, 2002 Abandoned
Array ( [id] => 6730714 [patent_doc_number] => 20030186904 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-10-02 [patent_title] => 'Keratinocyte growth factor-2' [patent_app_type] => new [patent_app_number] => 10/035212 [patent_app_country] => US [patent_app_date] => 2002-01-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 64 [patent_figures_cnt] => 64 [patent_no_of_words] => 144684 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0186/20030186904.pdf [firstpage_image] =>[orig_patent_app_number] => 10035212 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/035212
Keratinocyte growth factor-2 Jan 3, 2002 Abandoned
Menu